Constructing Implantable SrTiO3:Yb,Ho Nanofibers for NIR-Triggered and Optically Monitored Chemotherapy
Constructing Implantable SrTiO3:Yb,Ho Nanofibers for NIR-Triggered and Optically Monitored Chemotherapy
复制标题
构建用于近红外触发和光学监测化疗的植入式 SrTiO3:Yb,Ho 纳米纤维
DOI:
10.1002/chem.201604956
复制
发表时间:
2017
期刊:
影响因子:
--
通讯作者:
Han Gaorong
中科院分区:
文献类型:
--
作者:
Fu Yike;Fang Chao;Ren Zhaohui;Xu Gang;Li Xiang;Han Gaorong
Light‐responsive and photoluminescent (PL) drug‐delivery platforms have sparked fascinating advancements in personalized tumor chemotherapy due to their unique characteristics in biological imaging and manipulated release kinetics. Herein, implantable Yb3+and Ho3+co‐doped strontium titanate (SrTiO3:Yb,Ho) nanofibers were synthesized and decorated on the surface with polyacrylic acid (PAA) molecules. The preliminary in vitro assay confirmed that this implantable fibrous mesh presented sound cytocompatibility. The PAA surface decoration improved the loading capacity of an anticancer drug (doxorubicin (DOX)) and effectively prevented a daunting burst release in a neutral aqueous environment. Owing to the electrostatic bond between PAA and DOX molecules, low‐pH microenvironments and NIR (λ=808 nm) irradiation both induced significantly accelerated DOX release and consequently enhanced the local cancer‐cell‐killing effect. Additionally, the ratio of green‐to‐red emission (I545/I655) from the SrTiO3:Yb,Ho‐PAA fibers responded effectively to the DOX release progress and dosage due to a fluorescence resonance energy transfer (FRET) effect. This unique characteristic enabled optical monitoring of the delivery progress in a timely manner. These SrTiO3:Yb,Ho‐PAA nanofibers, with precise dual‐triggering and optical monitoring of DOX release, are expected to serve as a new implantable drug delivery platform for personalized chemotherapy in the future.